Factor activador de célula B perteneciente a la familia del TNF (BAFF): Blanco terapéutico por su papel en autoinmunidad

Sutherland, 2006, Targeting BAFF: immunomodulation for autoimmune diseases and lymphomas, Pharmacol Ther, 112, 774, 10.1016/j.pharmthera.2006.06.002 Schneider, 1999, BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth, J Exp Med, 189, 1747, 10.1084/jem.189.11.1747 Moore, 1999, BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator, Science, 285, 260, 10.1126/science.285.5425.260 Tribouley, 1999, Characterization of a new member of the TNF family expressed on antigen presenting cells, Biol Chem, 380, 1443, 10.1515/BC.1999.186 Shu, 1999, TALL-1 is a novel member of the TNF family that is down-regulated by mitogens, J Leukoc Biol, 65, 680, 10.1002/jlb.65.5.680 Mukhopadhyay, 1999, Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2- terminal kinase, J Biol Chem, 274, 15978, 10.1074/jbc.274.23.15978 Schneider, 2005, The role of APRIL and BAFF in lymphocyte activation, Curr Opin Immunol, 17, 282, 10.1016/j.coi.2005.04.005 Mackay, 2003, The TNF family members BAFF and APRIL: the growing complexity, Cytokine Growth Factor Rev, 14, 311, 10.1016/S1359-6101(03)00023-6 Bodmer, 2002, The molecular architecture of the TNF superfamily, Trends Biochem Sci, 27, 19, 10.1016/S0968-0004(01)01995-8 Mackay, 2002, The role of BAFF in B-cell maturation, T-cell activation and autoimmunity, Trends Immunol, 23, 113, 10.1016/S1471-4906(01)02159-7 Bossen, 2006, BAFF, APRIL and their receptors: structure, function and signaling, Semin Immunol, 18, 263, 10.1016/j.smim.2006.04.006 Roschke, 2002, BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases, J Immunol, 169, 4314, 10.4049/jimmunol.169.8.4314 Reyes, 2006, BAFF: Una citoquina reguladora de linfocitos B implicada en autoinmunidad y cáncer linfoide, Rev Med Chile, 134, 1175, 10.4067/S0034-98872006000900014 Gorelik, 2003, Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells, J Exp Med, 198, 937, 10.1084/jem.20030789 Ohata, 2005, Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines, J Immunol, 174, 864, 10.4049/jimmunol.174.2.864 Krumbholz, 2005, BAFF is produced by astrocytes and upregulated in multiple sclerosis lesions and primary central nervous system lymphoma, J Exp Med, 201, 195, 10.1084/jem.20041674 Brink, 2006, Regulation of B cell self-tolerance by BAFF, Semin Immunol, 18, 276, 10.1016/j.smim.2006.04.003 Ye, 2004, BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses, Eur J Immunol, 34, 2750, 10.1002/eji.200425198 Mackay, 2006, The role of the BAFF/APRIL system on T cell function, Semin Immunol, 18, 284, 10.1016/j.smim.2006.04.005 Woodland, 2006, BLyS and B cell homeostasis, Semin Immunol, 18, 318, 10.1016/j.smim.2006.06.001 Dejardin, 2006, The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development, Biochem Pharmacol, 72, 1161, 10.1016/j.bcp.2006.08.007 Craxton, 2005, BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway, J Exp Med, 202, 1363, 10.1084/jem.20051283 Shinners, 2007, Bruton's Tyrosine Kinase Mediates NF-{kappa}B Activation and B Cell Survival by B Cell-Activating Factor Receptor of the TNF-R Family, J Immunol, 179, 3872, 10.4049/jimmunol.179.6.3872 Khare, 2000, Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice, Proc Natl Acad Sci U S A, 97, 3370, 10.1073/pnas.97.7.3370 Mackay, 1999, Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations, J Exp Med, 190, 1697, 10.1084/jem.190.11.1697 Stohl, 2005, BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus, Arthritis Rheum, 52, 2080, 10.1002/art.21138 Wang, 2001, TACI-ligand interactions are required for T cell activation and collagen-induced arthritis in mice, Nat Immunol, 2, 632, 10.1038/89782 Zheng, 2005, A role for B cell-activating factor of the TNF family in chemically induced autoimmunity, J Immunol, 175, 6163, 10.4049/jimmunol.175.9.6163 Zhang, 2001, Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus, J Immunol, 166, 6, 10.4049/jimmunol.166.1.6 Lin, 2007, Preliminary clinical measurement of the expression of Bcell activating factor in Chinese systemic lupus erythematosus patients, J Clin Lab Anal, 21, 183, 10.1002/jcla.20161 Pers, 2005, BAFF overexpression is associated with autoantibody production in autoimmune diseases, Ann N Y Acad Sci, 1050, 34, 10.1196/annals.1313.004 Krumbholz, 2005, BAFF is elevated in serum of patients with Wegener's granulomatosis, J Autoimmun, 25, 298, 10.1016/j.jaut.2005.08.004 Daridon, 2007, Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjogren's syndrome, Arthritis Rheum, 56, 1134, 10.1002/art.22458 Matsushita, 2007, Elevated serum BAFF levels in patients with localized scleroderma in contrast to other organ-specific autoimmune diseases, Exp Dermatol, 16, 87, 10.1111/j.1600-0625.2006.00485.x Kawasaki, 2002, Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis, Genes Immun, 3, 424, 10.1038/sj.gene.6363923 Stohl, 2002, B lymphocyte stimulator protein-associated increase in circulating autoantibody levels may require CD4+T cells: lessons from HIV-infected patients, Clin Immunol, 104, 115, 10.1006/clim.2002.5238 Novak, 2002, Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival, Blood, 100, 2973, 10.1182/blood-2002-02-0558 Novak, 2004, Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome, Blood, 104, 2247, 10.1182/blood-2004-02-0762 Chiu, 2007, Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL, Blood, 109, 729, 10.1182/blood-2006-04-015958 Elsawa, 2006, B-lymphocyte stimulator (BLyS) stimulates immunoglobulin production and malignant B-cell growth in Waldenstrom macroglobulinemia, Blood, 107, 2882, 10.1182/blood-2005-09-3552 Novak, 2004, Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival, Blood, 103, 689, 10.1182/blood-2003-06-2043 Tangye, 2006, BAFF, APRIL and human B cell disorders, Semin Immunol, 18, 305, 10.1016/j.smim.2006.04.004 Migita, 2007, Elevated serum BAFF levels in patients with autoimmune hepatitis, Hum Immunol, 68, 586, 10.1016/j.humimm.2007.03.010 Knight, 2007, High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency, Clin Immunol, 124, 182, 10.1016/j.clim.2007.04.012 Kang, 2006, B cell-activating factor is a novel diagnosis parameter for asthma, Int Arch Allergy Immunol, 141, 181, 10.1159/000094897 Chatzantoni, 2006, Anti-TNF-alpha antibody therapies in autoimmune diseases, Curr Top Med Chem, 6, 1707, 10.2174/156802606778194217 Bosello, 2007, BAFF and rheumatic autoimmune disorders: implications for disease management and therapy, Int J Immunopathol Pharmacol, 20, 1, 10.1177/039463200702000101 Taylor, 2007, Drug insight: the mechanism of action of rituximab in autoimmune disease--the immune complex decoy hypothesis, Nat Clin Pract Rheumatol, 3, 86, 10.1038/ncprheum0424 Cartron, 2007, Pharmacokinetics of rituximab and its clinical use: thought for the best use?, Crit Rev Oncol Hematol, 62, 43, 10.1016/j.critrevonc.2006.09.004 Liu, 2004, Control of spontaneous B lymphocyte autoimmunity with adenovirusencoded soluble TACI, Arthritis Rheum, 50, 1884, 10.1002/art.20290 LymphoStat-B® (Belimumab). Consultado 02 Sept (2007) En: http://www.hgsi.com/products/LSB.html Binard, 2007, BAFF, A newcomer to the lupus party, Lupus, 16, 699, 10.1177/0961203307081512